We strategically use our resources to support and advance a range of vaccine candidates as well as cross-cutting activities.
EVI supports a diverse portfolio of preclinical, early clinical, and advanced clinical projects.
Pre-clinical proof of concept
Clinical proof of concept
Diseases of Poverty
Translational Vaccine R&D